Evidence map›Paper›PMID 39000070›Full record

ArticleInternational journal of molecular sciences2024

Bone Marrow-Suppressive Treatment in Children Is Associated with Diminished IFN-γ Response from T Cells upon Polyclonal and Varicella Zoster Virus Peptide Stimulation.

Eva Tiselius, Emil Sundberg, Hanna Andersson, Anna Höbinger, Peter Jahnmatz, Arja Harila, Josefine Palle, Anna Nilsson, Shanie Saghafian-Hedengren

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Eva TiseliusDepartment of Women's and Children's Health, Division of Pediatric Oncology and Pediatric Surgery, Karolinska Institutet, 171 77 Stockholm, Sweden.
Emil SundbergDepartment of Women's and Children's Health, Uppsala University, 751 05 Uppsala, Sweden.ORCID 0000-0001-5087-1400
Hanna AnderssonDepartment of Women's and Children's Health, Division of Pediatric Oncology and Pediatric Surgery, Karolinska Institutet, 171 77 Stockholm, Sweden.
Anna HöbingerDepartment of Women's and Children's Health, Division of Pediatric Oncology and Pediatric Surgery, Karolinska Institutet, 171 77 Stockholm, Sweden.
Peter JahnmatzMabtech AB, 131 52 Nacka Strand, Sweden.
Arja HarilaDepartment of Women's and Children's Health, Uppsala University, 751 05 Uppsala, Sweden.
Josefine PalleDepartment of Women's and Children's Health, Uppsala University, 751 05 Uppsala, Sweden.
Anna NilssonDepartment of Women's and Children's Health, Division of Pediatric Oncology and Pediatric Surgery, Karolinska Institutet, 171 77 Stockholm, Sweden.ORCID 0000-0001-5885-7101
Shanie Saghafian-HedengrenDepartment of Women's and Children's Health, Division of Pediatric Oncology and Pediatric Surgery, Karolinska Institutet, 171 77 Stockholm, Sweden.

Funding

Barncancerfonden KP2021-0034Lions Cancer Foundation, Uppsala University Hospital N/ASwedish Research Council VR 2020-02244
6 · The paper itself

Abstract

Severe haematological diseases and lymphoid malignancies require bone marrow (BM)-suppressive treatments. Knowledge regarding the impact of BM-suppressive treatments on children's memory T cells is very limited. Memory T cells play a crucial role in defending against herpesviruses, which is particularly relevant in paediatric cancer care. We studied 53 children in total; 34 with cancer and 2 with severe haematological disorders, with some receiving BM-suppressive treatment with or without allogeneic-haematopoietic stem cell transplantation (allo-HSCT), alongside 17 healthy controls. We focused on peripheral blood proportions of memory T-cell subsets using flow cytometry and analysed cytokine-secreting T cells with a four-parameter FluoroSpot assay in response to T-cell mitogen and varicella zoster virus (VZV) peptides. Patients on BM-suppressive treatment showed increased clusters of differentiation (CD)4

Indexed as

Herpesvirus 3, HumanInterferon-gammaAdolescentBone MarrowChildChild, PreschoolFemaleHematopoietic Stem Cell TransplantationHumansMaleMemory T CellsT-LymphocytesInterferon-gammachildrenIFN-γlymphoid malignancymemory T cellvaricella

Identifiers

PMID39000070
PMCPMC11241059

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.